Weitz Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.1M Sell
653,200
-149,750
-19% -$8.99M 2.38% 14
2025
Q4
$47.2M Buy
802,950
+800
+0.1% +$48.6K 2.8% 14
2025
Q3
$44.6M Hold
802,150
2.42% 16
2025
Q2
$41.3M Buy
802,150
+10,500
+1% +$528K 2.22% 19
2025
Q1
$46.4M Buy
791,650
+410,400
+108% +$27.8M 2.47% 16
2024
Q4
$27.5M Buy
381,250
+334,050
+708% +$24.5M 1.42% 29
2024
Q3
$3.77M Buy
47,200
+3,100
+7% +$233K 0.19% 46
2024
Q2
$3.16M Buy
+44,100
New +$3.25M 0.17% 49

Other funds holding TECH

Weitz Investment Management's TECH Position: Q1 2026 in Review

Weitz Investment Management reduced its Bio-Techne (TECH) stake by 19% in Q1 2026, selling an estimated $8.99M and leaving 653,200 shares worth $34.1M. The position accounts for 2.38% of the portfolio, ranked #14.

Weitz Investment Management first reported a position in TECH in Q2 2024 and has held it in 8 quarters since. The position peaked at $47.2M in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Weitz Investment Management held 653,200 shares of Bio-Techne worth $34.1M as of Q1 2026.
  • Weitz Investment Management sold 149,750 Bio-Techne shares in Q1 2026, an estimated $8.99M.
  • Bio-Techne made up 2.38% of Weitz Investment Management's portfolio in Q1 2026, its #14 holding.
  • Weitz Investment Management first reported a position in Bio-Techne in Q2 2024 and has held it in 8 quarters since.
  • Weitz Investment Management's Bio-Techne position peaked at $47.2M in Q4 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Weitz Investment Management's 13F filing for Q1 2026, filed 14 May 2026.